Northpointe Bancshares, Inc. operates as the bank holding company for Northpointe Bank provides various banking products and services in the United States.
$15.76-0.76%
报价 2026-11-06
市值
$545M
EV
$1.29B
PE (TTM)
3.0x
预期 PE (FY2026)
7.1x
52 周区间距高点 -18.4%
$14.57$19.31
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Banks - Regional
爆发潜力
2026-11-07不在筛选范围：industry: Banks - Regional
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NPBNorthpointe Bancshares, Inc. | $545M | -0.8% | +11.1% | 50.9% | 3.0x | 11.4x | 6.9x | |
| ERASErasca, Inc. | $5.04B | +8.6% | +837.5% | 0% | – | – | – | |
| LEGNLegend Biotech Corporation | $4.33B | +3.8% | +39.4% | 55% | – | – | – | |
| ZLABZai Lab Limited | $2.87B | +12.7% | – | 56.5% | – | – | – | |
| CGEMCullinan Therapeutics, Inc. | $695.1M | +4.7% | +142.3% | 0% | – | – | – | |
| CCCCC4 Therapeutics, Inc. | $381.4M | +5.1% | -25.0% | 94.9% | – | – | – | |
| ALXOALX Oncology Holdings Inc. | $159.7M | +0.4% | +666.7% | 0% | – | – | – | |
| BNRBurning Rock Biotech Limited | $14.2M | +1.3% | – | 74.6% | – | – | – | |
| 同行中位数 | – | – | +142.3% | 55% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。